Global /Taiwan /Healthcare /Medical Distribution /3118

Level Biotechnology Inc.

3118

• TPEX: 3118 • Delayed

33.60TWD -0.4%

1.06 USD

As of 13 June 2026, Level Biotechnology Inc. has a market cap of $34.68M USD, ranking #33223 globally and #2033 in Taiwan. It ranks #3002 in the Healthcare sector, and #124 in the Medical Distribution industry.

Global Rank

33223

Country Rank

2033

Sector Rank

3002

Industry Rank

124

Key Stats

Market Cap

$34.68MUSD

1.1B TWD

Enterprise Value

$28.26MUSD

892.93M TWD

Revenue (TTM)

$23.32MUSD

736.59M TWD

EBITDA (TTM)

$3.18MUSD

100.43M TWD

Net Income (TTM)

$2.52MUSD

79.7M TWD

EBITDA Margin

14%

Profit Margin

11%

PE Ratio

13.8

PS Ratio

1.5

PB Ratio

1.9

EV/EBITDA

8.4

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Distribution

CEO

Chun Long Qiu open_in_new

Employees

128

Founded

1989

Website

level.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.4%	0.1%	1.4%	2.4%	-0.4%	2.3%	6%	4.5%	5.1%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	3118 進階生物科技股份有限公司 ISIN: TW0003118006 Shares Out.: Shares Outstanding: 32.453M¹ Shares Float: 22.614M² TV: TradingView: TPEX: 3118 SA: Stock Analysis: TPEX: 3118 YF: Yahoo Finance: 3118.TWO GF: Google Finance: TPEX: 3118 BA: Barron's: 3118 MS: Morningstar: ROCO: 3118	33.60 TWD	TV: TradingView: TPEX: 3118 SA: Stock Analysis: TPEX: 3118 YF: Yahoo Finance: 3118.TWO GF: Google Finance: TPEX: 3118 BA: Barron's: 3118 MS: Morningstar: ROCO: 3118

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Level Biotechnology Inc.

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. The company markets and distributes biomedical precision equipment. It also provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. In addition, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.

Similar Companies

Industry: Medical Distribution (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Excelsior Medical Co., Ltd. TWSE: 4104	$387.89M 12.25B TWD 1K%	15.3	Taiwan
Gongwin Biopharm Holdings Co., Ltd. TPEX: 6617	$292.76M 9.25B TWD 744%	-	Taiwan
CHC Healthcare Group TWSE: 4164	$182.13M 5.75B TWD 425%	29.5	Taiwan
WeLeader Biomedical Co., Ltd. TPEX: 7713	$97.2M 3.07B TWD 180%	14.9	Taiwan
ShareHope Medicine Co., Ltd. TPEX: 8403	$93.92M 2.97B TWD 171%	20.9	Taiwan
Eyecare Tech Inc. TPEX: 7881	$82.07M 2.59B TWD 137%	-	Taiwan

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 290K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 175K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 138K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 24K%	22.6	United States
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 21K%	7.2	China
Galenica AG SIX: GALE	$5.27B 4.2B CHF 15K%	23.0	Switzerland

chevron_leftBack